Are you Dr. Berhe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3409 Worth St
710
Dallas, TX 75246Phone+1 214-823-2533Fax+1 214-824-8679
Summary
- Dr. Mezgebe Berhe, MD is an infectious disease specialist in Dallas, Texas. He is currently licensed to practice medicine in Texas and Virginia.
Certifications & Licensure
TX State Medical License 2005 - 2026
VA State Medical License 2003 - 2006
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase...Indira Brar, Peter J Ruane, Mezgebe Berhe, Cynthia Brinson, Paul Benson
Medicine. 2025-02-21 - 10 citationsSustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.Charlotte-Paige Rolle, Mezgebe Berhe, Tulika Singh, Roberto Ortiz, Anson Wurapa
Open Forum Infectious Diseases. 2023-03-01 - 37 citationsLenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-c...Samir K Gupta, Mezgebe Berhe, Gordon Crofoot, Paul Benson, Moti Ramgopal
The Lancet. HIV. 2023-01-01
Press Mentions
Booster Shot May Be on Horizon for J&J Vaccine RecipientsAugust 25th, 2021- NTIDC Researchers: Pfizer Vaccine Is Safe, Ready to GoNovember 27th, 2020
- More Than 2,500 Healthcare Providers Sign up to Administer Coronavirus Vaccine in TexasNovember 11th, 2020
- Join now to see all
